North Korea attempts to hack South Korean coronavirus vaccine firms

A member of the parliamentary intelligence committee said the agency did not specify which drugmakers were targeted but said there was no damage from the hacking attempts. EPA-EFE/MARTIN JOPPEN / SANOFI / HANDOUT HANDOUT EDITORIAL USE ONLY/NO SALES

A handout photo made available by Sanofi shows ampoules of a possible Covid-19 vaccine during the production in Frankfurt am Main, Germany, 15 September 2020 (issued 22 September 2020). If all clinical testings are successful, Sanofi expects application for approval oft he vaccine in the first half of 2021. style=”font-size:40px; line-height: 1.3em; font-weight: 800; padding:7px;”>North Korea attempts to hack South Korean coronavirus vaccine firms

By Elena Pavlovska
Journalist

epa08688476 A handout photo made available by Sanofi shows ampoules of a possible Covid-19 vaccine during the production in Frankfurt am Main, Germany, 15 September 2020 (issued 22 September 2020). According to Sanofi, clinical testing of this vaccine candidate began in early September. Last week, Microsoft found that hackers working for Russia and North Korea targeted pharmaceutical companies and vaccine researchers in Canada, France, India, South Korea and the United States. According to Sanofi, clinical testing of this vaccine candidate began in early September. The pharmaceutical company Sanofi officially started the production of its potential vaccine against COVID-19 in Frankfurt on 22 September 2020 to ensure that protection against corona infection is immediately available at the time of approval. North Korea has not confirmed any coronavirus infection, but the NIS had said an outbreak there cannot be ruled out as the country had active trade exchanges with China before closing the border in January. EPA-EFE/MARTIN JOPPEN / SANOFI /

Facebook

Twitter

Linkedin

WhatsApp

Viber

Email

Print

South Korea’s National Intelligence Service (NIS) foiled North Korean attempts to hack into South Korean companies developing coronavirus vaccines, lawmakers said on Friday. If all clinical testings are successful, Sanofi expects application for approval oft he vaccine in the first half of 2021. The pharmaceutical company Sanofi officially started the production of its potential vaccine against COVID-19 in Frankfurt on 22 September 2020 to ensure that protection against corona infection is immediately available at the time of approval. The hacking attempt was part of a series of “unreasonable” actions taken by North Korea due to COVID-19 “paranoia”, the lawmakers said. In July, Chinese-backed hackers were also accused of targeting Moderna in a bid to steal vaccine research data.